Milestone Scientific (AMEX:
MLSS) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.23 million which missed the analyst consensus estimate of $2.43 million by 8.32 percent. This is a 0.76 percent decrease over sales of $2.25 million the same period last year.